Name | Type | Posted | Actions |
|---|---|---|---|
Amendment_5to_the_RFP_-_10-18-2024_0005.pdf | Oct 18, 2024 | ||
Amendment_4_to_the_RFP_-_10-11-2024_0004.pdf | Oct 11, 2024 | ||
Amendment_3_to_the_RFP_-_10-08-2024_0003.pdf | Oct 8, 2024 | ||
Amendment_2_to_the_RFP_-_9-20-24_0002.pdf | Sep 20, 2024 | ||
Amendment_1_to_RFP_75N94024R00008_9-11-24_0001.pdf | Sep 11, 2024 | ||
Sol_75N94024R00008.pdf | Sep 4, 2024 |
A--BPCA Pediatric Trials Network
A--BPCA Pediatric Trials Network
Contact and place of performance
OSINSKI, ELIZABETH J
Not specified
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), issued solicitation number 75N94024R00008 for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN). This requirement is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for Health R&D Services; Health Care Services; Basic Research.
The procurement supports the establishment and operation of a network dedicated to pediatric clinical trials as part of the Best Pharmaceuticals for Children Act. Responses to this solicitation are due by November 4, 2024, with Elizabeth J. Osinski serving as the point of contact.
This notice was originally published on September 4, 2024, and received its most recent update on October 18, 2024. The solicitation includes six total PDF attachments consisting of the original request for proposals and five subsequent amendments issued between September 11 and October 18, 2024.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.